- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Woody Eisenberg on Choosing Appropriate Measures
Picking the right measurements to assess improvement in medication management depends largely on the what group is being considered, said Woody Eisenberg, MD, senior vice president of performance measurement and strategic alliances for the Pharmacy Quality Alliance.
senior vice president of performance measurement and strategic alliances for the Pharmacy Quality Alliance (PQA).
Picking the right measurements to assess improvement in medication management depends largely on the what group is being considered, said Woody Eisenberg, MD,
The Medicaid population has different needs from the Medicare population as well as the commercially insured population.
He went on to discuss that while PQA does not currently take affordability into its measurement processes yet, it is looking into it.
"As we're moving forward, I know that one of our measurement teams or another will be focused on this topic," Dr Eisenberg said.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
